Introduction: Lipodystrophy is a term used to describe a metabolic complication of fat loss, fat
gain, or a combination of fat loss and gain, which is associated with some antiretroviral …

Morphologic and metabolic abnormalities, including subcutaneous adipose tissue wasting,
central adipose tissue accumulation, dyslipidemia and disorders of glucose metabolism are …

Objective: To assess lipoatrophy, other toxicities, and efficacy associated with abacavir as
compared with stavudine in HIV-infected antiretroviral-naive patients. Methods: This was a …

Objective: This study measured the prevalence of lipodystrophy and the metabolic effects of
highly active antiretroviral therapy (HAART) in HIV-infected African subjects. Methods …

Background: Data describing the true extent of antiretroviral therapy (ART)–induced
dyslipidemia and insulin resistance in perinatally infected children on ART in Africa are …

Background: Whole body and abdominal obesity are associated with increased risk of
diabetes mellitus and heart disease. The effects of testosterone therapy on whole body and …

Background: Highly active antiretroviral therapy has brought about a substantial
improvement in the prognosis of HIV/AIDS. In this context, therapy-related body changes …

Purpose Patients with human immunodeficiency virus (HIV) are living longer with effective
antiretroviral therapies and are enjoying near normal life span. Therefore, they are …

Objective To review the initial clinical manifestations of congenital and acquired
lipodystrophy syndromes, discuss novel classifications associated with genetic mutations …

For many people living with HIV (PLHIV), disclosure or concealment of their HIV status may
be under their personal control; however, for PLHIV with visible symptoms of their illness …